<p>杰富瑞分析师 Roger Song 今天对 Kailera Therapeutics, Inc.维持买入评级，并设定目标价为 48.00 美元。</p>
<h3>阵亡将士纪念日促销 – 享受 70% 的折扣</h3>
<ul>
<li>通过 TipRanks Premium 解锁值得信赖的数据驱动投资工具，从分析师评级和预测到突发新闻和投资组合分析。</li>
<li>通过 TipRanks 智能投资者通讯发现高信心股票推荐和新的投资机会。</li>
</ul>
<p>Song 覆盖医疗保健行业，专注于 United Therapeutics、Oruka Therapeutics 和 Fate Therapeutics 等股票。根据 TipRanks，Song 推荐股票的平均回报为 0.5%，成功率为 40.86%。</p>
<p>市场普遍认为，Kailera Therapeutics, Inc.的分析师共识评级为强烈买入，平均目标价为 39.00 美元。</p>

KLRA

<p>Jefferies 分析师 Roger Song 对 Kailera Therapeutics, Inc. (KLRA) 维持了买入评级，目标价为 48.00 美元。分析师共识建议该公司的评级为强烈买入，平均目标价为 39.00 美元。Song 在他的股票推荐中成功率为 40.86%</p>

<p>Jefferies analyst Roger Song maintained a Buy rating on Kailera Therapeutics, Inc. today and set a price target of $48.00.</p>
<div class="lb-trans"><p>杰富瑞分析师 Roger Song 今天对 Kailera Therapeutics, Inc.维持买入评级，并设定目标价为 48.00 美元。</p>
</div><h3>Memorial Day Sale – Claim 70% Off TipRanks</h3>
<div class="lb-trans"><h3>阵亡将士纪念日促销 – 享受 70% 的折扣</h3>
</div><ul>
<li>Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.</li>
<li>Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter</li>
</ul>
<div class="lb-trans"><ul>
<li>通过 TipRanks Premium 解锁值得信赖的数据驱动投资工具，从分析师评级和预测到突发新闻和投资组合分析。</li>
<li>通过 TipRanks 智能投资者通讯发现高信心股票推荐和新的投资机会。</li>
</ul>
</div><p>Song covers the Healthcare sector, focusing on stocks such as United Therapeutics, Oruka Therapeutics, and Fate Therapeutics. According to TipRanks, Song has an average return of 0.5% and a 40.86% success rate on recommended stocks.</p>
<div class="lb-trans"><p>Song 覆盖医疗保健行业，专注于 United Therapeutics、Oruka Therapeutics 和 Fate Therapeutics 等股票。根据 TipRanks，Song 推荐股票的平均回报为 0.5%，成功率为 40.86%。</p>
</div><p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Kailera Therapeutics, Inc. with a $39.00 average price target.</p>
<div class="lb-trans"><p>市场普遍认为，Kailera Therapeutics, Inc.的分析师共识评级为强烈买入，平均目标价为 39.00 美元。</p>
</div>

Jefferies 维持对 Kailera Therapeutics, Inc. (KLRA) 的买入评级